The research, which used animal models, focused on pancreatic ductal adenocarcinoma, which accounts for 90% of pancreatic cancer cases.

Scientists stated that combining the two therapies allows them to focus on eradicating ‘bad’ T-cells within the immune system.

Radiation and a new immunotherapy can induce a significant systemic memory immune response resulting in an anti-tumor effect achieving eradication, even after being rechallenged.

When a disease is metastatic, you want to recognize and attack the cell type everywhere, from the pancreas to the liver, blood and more.

This is the first time we’ve seen the eradication of a pancreatic tumor that suggests the cancer cell has memory, meaning we can stop the disease from coming back.

pll/jcm/joe